Background Atherosclerotic cardiovascular disease (ASCVD) imposes a substantial clinical and economic burden in China. Despite maximally tolerated statin therapy, many patients fail to achieve recommended low-density lipoprotein cholesterol (LDL-C) targets. I… संपूर्ण बातमीसाठी मूळ स्रोताला भेट द्या.
आरोग्य
Cost-effectiveness of inclisiran in patients with atherosclerotic cardiovascular disease from Chinese healthcare perspective
Background Atherosclerotic cardiovascular disease (ASCVD) imposes a substantial clinical and economic burden in China. Despite maximally tolerated statin therapy, many patients fail to achieve recommended low-density lipoprotein cholesterol (LDL-C) targets. I…
लेखक: Mochou Liu, Xinyue Zhang, Mengwen Feng, Qingfeng He, Zhen Feng· Plos.org· · २ मिनिटांचे वाचन
हा सारांश Plos.org येथून घेतला आहे. संपूर्ण बातमी येथे वाचा:Plos.org